Teradyne (TER) CFO Receives New Hire Equity Compensation Grant
TERADYNE, INC
Subscribe to track TER
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Teradyne (TER) CFO Receives New Hire Equity Grant
Company: TERADYNE, INC (TER) Form: 4 | Filed: 2025-11-05 Significance: Low
Insider: Turner Michelle L. Title: Chief Financial Officer | Relationship: Officer
Transaction (RSU Grant): • Type: Grant • Shares: 11,144 • Price: $0.00 • Value: $0 • Owned After: 11,260
Key Insight: This is a standard equity compensation grant for the company's CFO. The transaction is not an open-market purchase and has a negligible dilutive effect, representing a routine corporate action.
Market Context: The grant of 11,144 RSUs and an additional 9,156 stock options represents less than 0.02% of the company's total shares outstanding, which is immaterial for a company with a market cap of over $28 billion.
Comprehensive Analysis
SEC Filing Analysis: TERADYNE, INC (TER)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Financial Officer, Michelle L. Turner, received a standard new hire equity compensation package, consisting of Restricted Stock Units (RSUs) and stock options. This is a non-market transaction with minimal impact.
- Market Impact: Neutral. This is a routine compensation grant, not an open-market trade, and is unlikely to influence the stock price.
Company Information
| Field | Value |
|---|---|
| Company | TERADYNE, INC |
| Ticker Symbol | TER |
| CIK | 0000097210 |
| Industry | INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] |
Insider Information
| Field | Value |
|---|---|
| Name | Turner Michelle L. |
| CIK | 0001907247 |
| Title/Position | Chief Financial Officer |
| Relationship | Officer |
Transaction Details
This filing reports two grants: a non-derivative grant of RSUs and a derivative grant of stock options. The details below are for the RSU grant.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | A (Grant) |
| Security Type | Common Stock (as RSUs) |
| Shares Involved | 11,144 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 11,260 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Grant) |
| % of Market Cap | 0.0% |
| Shares Transacted (RSUs) | 11,144 |
| % of Shares Outstanding | 0.007% |
| Post-Transaction Ownership | 11,260 shares (0.0071% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $28.47 billion, this equity grant is a routine part of executive compensation and is financially immaterial.
- Ownership Concentration: The insider's post-transaction ownership of 11,260 shares remains a very small fraction (0.0071%) of the total shares outstanding, indicating no significant shift in ownership concentration.
- Dilution Impact: The grant includes 11,144 RSUs and 9,156 stock options, totaling 20,300 potential shares. This represents a potential dilution of only 0.0128% of total shares outstanding, which is negligible for existing shareholders.
- Transaction Significance: The transaction's value and share volume are far below the thresholds for moderate or high significance. It is a standard corporate governance action to align executive and shareholder interests.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants are a form of compensation and are not indicative of an insider's market sentiment in the same way an open-market purchase or sale is. The market does not typically react to such routine filings.
Volume & Sentiment
- Expected Volume Impact: None. As this is not a market transaction, it will not directly impact trading volume.
- Sentiment Indicator: Neutral. This filing provides no new information to alter market sentiment towards the stock.
Additional Context
Transaction Notes
- Vesting Schedule: The RSUs vest in four equal annual installments starting November 3, 2026. The stock options also vest over four years, beginning on the first anniversary of the grant. This long-term vesting schedule is designed to retain the executive and align their performance with the company's long-term success.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
